Amgen (AMGN) Other Operating Expenses (2009 - 2026)

Amgen has reported Other Operating Expenses for 18 years, with the latest figure at $2.8 billion in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 6.64% year-over-year to $2.8 billion in Q2 2026; TTM through Jun 2026 was $11.6 billion, a 6.35% decrease from a year earlier, with the FY2025 full-year figure at $12.0 billion, down 6.39% from the prior year.
• Other Operating Expenses was $2.8 billion for Q2 2026 at Amgen, up from $2.7 billion in the prior quarter.
• The five-year high for Other Operating Expenses was $3.3 billion in Q3 2024, with the low at $1.6 billion in Q1 2022.
• Average Other Operating Expenses over 5 years is $2.6 billion, with a median of $2.9 billion recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses slumped 34.69% in 2022, then soared 81.96% in 2023.
• Over 5 years, Other Operating Expenses stood at $1.7 billion in 2022, then jumped by 81.96% to $3.1 billion in 2023, then slipped by 0.16% to $3.1 billion in 2024, then declined by 4.37% to $3.0 billion in 2025, then fell by 5.54% to $2.8 billion in 2026.
• The last three Other Operating Expenses figures came in at $2.8 billion (Q2 2026), $2.7 billion (Q1 2026), and $3.0 billion (Q4 2025), per Business Quant data.